Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to letter bearing Ref: DIL:DIL/BSE/2018-19/F.No.:S-23/ DE05 dated November 2, 2018, regarding meeting of the Board of Directors of the Company scheduled on November 13, 2018, DIL has informed about the submission of a photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 6 and Sakal, Mumbai (Marathi version) on page no. 5 dated November 3, 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1666.00 |
| Dr. Reddys Lab | 1229.50 |
| Cipla | 1228.15 |
| Zydus Lifesciences | 934.00 |
| Lupin | 2329.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: